Target M0036153060Recalls & reported problems
Stryker Corporation · 3D Detachable Coil · Class 2 · Implant
All models of TARGET (114)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07613327004823), received between May 4, 2020 and May 4, 2020 — classified as 1 malfunction.
The most frequently reported specific device problem is “Premature Separation” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Premature Separation1
Patient problems
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 4, 2020Premature Separation; Premature Separation
IT WAS REPORTED THAT DURING THE PROCEDURE THAT THE SUBJECT COIL WAS FRAMED WITHIN THE ANEURYSM. PHYSICIAN PROCEEDED THE WITH DETACHMENT PROCESSES AND NOTED A LONG BEEP ON THE DETACHMENT DEVICE. SUBJECT COIL WAS NOT DETACHED AND WAS ATTEMPTED TO INSERT AGAIN. FRICTION WAS FELT UPON REINSERTION AND WAS NOTED TO BE PREMATURELY DETACHED UPON PULLING SUBJECT COIL BACK. SUBJECT COIL WAS THEN PUSHED WITH ANOTHER WIRE INTO THE ANEURYSM AND WAS PLACED NEAR THE BIFURCATION OF THE POSTERIOR COMMUNICATING ARTERY. BLOOD VESSELS WERE PRESERVED BY CONFIRMATION OF 3D-DSA. THE PROCEDURE WAS COMPLETED SUCCESSFULLY AND NO KNOWN CLINICAL CONSEQUENCES WERE REPORTED TO THE PATIENT DUE TO THIS EVENT. NO FURTHER INFORMATION IS CURRENTLY AVAILABLE.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 10022714 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page